Literature DB >> 23135283

PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells.

Hai-Sheng Zhang1, Bing Yan, Xue-Bing Li, Li Fan, Yun-Fang Zhang, Guo-Hao Wu, Min Li, Jing Fang.   

Abstract

Paired box (PAX) 2, a transcription factor, plays a critical role in embryogenesis. When aberrantly expressed in adult tissues, it generally exhibits oncogenic properties. However, the underlying mechanisms remain unclear. We reported previously that the expression of PAX2 was up-regulated in human colon cancers. However, the role of PAX2 in colon cancer cells has yet to be determined. The aim of this study is to determine the function of PAX2 in colon cancer cells and to investigate the possible mechanisms underlain. We find that knockdown of PAX2 inhibits proliferation and xenograft growth of colon cancer cells. Inhibition of PAX2 results in a decreased expression of cyclin D1. Expression of cyclin D1 is found increased in human primary colon malignant tumors, and its expression is associated with that of PAX2. These data indicate that PAX2 is a positive regulator of expression of cyclin D1. We find that knockdown of PAX2 inhibits the activity of AP-1, a transcription factor that induces cyclin D1 expression, implying that PAX2 induces cyclin D1 through AP-1. PAX2 has little effect on expression of AP-1 members including c-Jun, c-Fos, and JunB. Our data show that PAX2 prevents JunB from binding c-Jun and enhances phosphorylation of c-Jun, which may elevate the activity of AP-1. Taken together, these results suggest that PAX2 promotes proliferation of colon cancer cells through AP-1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135283      PMCID: PMC3531732          DOI: 10.1074/jbc.M112.401521

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  AP-1: a double-edged sword in tumorigenesis.

Authors:  Robert Eferl; Erwin F Wagner
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

2.  Forkhead transcription factor FOXO3a protein activates nuclear factor κB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation.

Authors:  Zhaodong Li; Haisheng Zhang; Ying Chen; Li Fan; Jing Fang
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

3.  JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers.

Authors:  T Deng; M Karin
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

Review 4.  Role and regulation of activator protein-1 in toxicant-induced responses of the lung.

Authors:  Sekhar P M Reddy; Brooke T Mossman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-12       Impact factor: 5.464

5.  Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival.

Authors:  Aleksandra Muratovska; Chaoming Zhou; Shuji He; Paul Goodyer; Michael R Eccles
Journal:  Oncogene       Date:  2003-09-11       Impact factor: 9.867

6.  jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun.

Authors:  J Schütte; J Viallet; M Nau; S Segal; J Fedorko; J Minna
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

7.  Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

Authors:  R Chiu; P Angel; M Karin
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

8.  Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer.

Authors:  R Suto; K Tominaga; H Mizuguchi; E Sasaki; K Higuchi; S Kim; H Iwao; T Arakawa
Journal:  Gene Ther       Date:  2004-01       Impact factor: 5.250

9.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

10.  Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells.

Authors:  Stefano Buttiglieri; Maria Chiara Deregibus; Stefania Bravo; Paola Cassoni; Roberto Chiarle; Benedetta Bussolati; Giovanni Camussi
Journal:  J Biol Chem       Date:  2003-11-19       Impact factor: 5.157

View more
  13 in total

1.  Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65.

Authors:  Soon-Kyung Hwang; Alyson R Baker; Matthew R Young; Nancy H Colburn
Journal:  Carcinogenesis       Date:  2014-01-11       Impact factor: 4.944

2.  Knockdown of IRE1α inhibits colonic tumorigenesis through decreasing β-catenin and IRE1α targeting suppresses colon cancer cells.

Authors:  X-X Li; H-S Zhang; Y-M Xu; R-J Zhang; Y Chen; L Fan; Y-Q Qin; Y Liu; M Li; J Fang
Journal:  Oncogene       Date:  2017-08-21       Impact factor: 9.867

3.  Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis.

Authors:  Chao Huang; Hong Liu; Xiuli Gong; Bin Wen; Dan Chen; Jinyuan Liu; Fengliang Hu
Journal:  Mol Med Rep       Date:  2016-08-01       Impact factor: 2.952

4.  CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis.

Authors:  Kangmin Zhuang; Juchang Zhang; Man Xiong; Xianfei Wang; Xiaobei Luo; Lu Han; Yan Meng; Yali Zhang; Wenting Liao; Side Liu
Journal:  Cell Death Dis       Date:  2016-10-13       Impact factor: 8.469

5.  DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.

Authors:  Nan Jia; Jieyu Wang; Qing Li; Xiang Tao; Kaikai Chang; Keqin Hua; Yinhua Yu; Kwong-Kwok Wong; Weiwei Feng
Journal:  Oncotarget       Date:  2016-12-20

6.  Systematic identification of an integrative network module during senescence from time-series gene expression.

Authors:  Chihyun Park; So Jeong Yun; Sung Jin Ryu; Soyoung Lee; Young-Sam Lee; Youngmi Yoon; Sang Chul Park
Journal:  BMC Syst Biol       Date:  2017-03-15

7.  Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells.

Authors:  Chenxi Hu; Wei Zhuang; Yun Qiao; Bin Liu; Liang Liu; Kaiyuan Hui; Xiaodong Jiang
Journal:  Onco Targets Ther       Date:  2019-01-29       Impact factor: 4.345

8.  PAX2 Expression in Ovarian Cancer.

Authors:  Huijuan Song; Suet-Yan Kwan; Daisy I Izaguirre; Zhifei Zu; Yvonne T Tsang; Celestine S Tung; Erin R King; Samuel C Mok; David M Gershenson; Kwong-Kwok Wong
Journal:  Int J Mol Sci       Date:  2013-03-15       Impact factor: 5.923

9.  Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.

Authors:  Ibrahim El-Serafi; Manuchehr Abedi-Valugerdi; Zuzana Potácová; Parvaneh Afsharian; Jonas Mattsson; Ali Moshfegh; Moustapha Hassan
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Immunoexpression of cyclin D1 in colorectal carcinomas is not correlated with survival outcome.

Authors:  Jaudah Al-Maghrabi; Shagufta Mufti; Wafaey Gomaa; Abdelbaset Buhmeida; Mohammed Al-Qahtani; Mahmoud Al-Ahwal
Journal:  J Microsc Ultrastruct       Date:  2015-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.